• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Lophius Biosciences

edit

Lophius Biosciences is a young biotechnology company developing innovative products for the diagnosis of acute infectious and autoimmune diseases. The company is also offering custom-made services in the area of cell based bioactivity and quality tests for pharmaceutical agents. The core competencies of Lophius Biosciences are in the area of Immunology and T-cell diagnostics.

Recent Milestones

edit

• 
  Lophius Biosciences received $1.98M (€1.4M) in Venture Round funding. (7/19/11)
  Posted 7/19/11 at 5:24am via finsmes.com
• 
  Lophius Biosciences received $1.97M in Series B funding. (5/17/10)
  Posted 7/6/10 at 7:50pm via lophius.de
• 
  Lophius Biosciences added Michael Lutz as CEO.
  Posted 7/6/10 at 7:50pm

Videos

Screenshots

edit

Above: Home Page
Uploaded: 7/7/10

Sources

1. Closing of a 2nd financing round and appointment of a new CEO (lophius.de) [edit]
2. Lophius Biosciences Raises €1.4M from Existing Investors (finsmes.com) [edit]